Actively Recruiting
Molecular Characterization for Understanding Biliary Atresia
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2021-06-04
100
Participants Needed
2
Research Sites
573 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal cholestasis and liver transplantation in children. Little is known about the molecular mechanisms that drive BA. The purpose of this study is to collect the fluid samples, explanted liver tissue samples and dermal biopsy samples to enable investigators to perform the genetic and molecular analyses that might point to the gene(s) and cellular pathway involved in etiology of BA disease.
CONDITIONS
Official Title
Molecular Characterization for Understanding Biliary Atresia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of biliary atresia in patients
- Parents of biliary atresia patients
You will not qualify if you...
- No exclusion criteria specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hopital Necker enfants malades
Paris, De, France, 75015
Actively Recruiting
2
PRC Inserm
Paris, France, 75013
Not Yet Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here